Global Chronic Idiopathic Constipation Treatment Market Report By Type (Normal-transit constipation,Slow-transit constipation,Others), By Therapy Type (Pharmacological Therapy,Non-pharmacological Therapy), By Treatment Type (Medication (Prescription Drugs, Over the Counter Drugs),Surgery (Laparoscopic Rectopexy, Lateral internal sphincterotomy),Dietary Fiber), By Drugs (Serotonin-4 (5-Ht4) Receptor Agonist,Guanylate Cyclase-C Agonist,Laxatives,Stimulants,Others), By Route of Administration (Oral,Injectable), By End Users (Hospitals,Homecare,Specialty Clinics,Others), By Distribution Channel (Hospital Pharmacies,Retail Pharmacies,Others) And By Regions - Industry Trends, Size, Share, Growth, Estimation and Forecast, 2020-2027

ID:VMR11214173
February 2021
Report Formats:
The global demand for Chronic Idiopathic Constipation Treatment Market is presumed to reach the market size of nearly USD XX MN by 2027 from USD XX MN in 2020 with a CAGR of XX% under the study period 2021 - 2027.

Chronic idiopathic constipation (CIC) treatment is used to treat functional lower gastrointestinal disorders called the CIC. CIC is not the same as irritable bowel syndrome (IBS). CIC is characterized by laborious, infrequent, and incomplete defecation and the cause is generally unknown. Various CIC treatment options are available to choose from, like increasing dietary fiber intake, medications like laxatives or biofeedback. There are three subtypes of CIC diagnosed so far. The treatment method selection depends primarily on the cost, tolerability, safety, patient preference, lifestyle considerations, and other pertinent clinical information. CIC can occur in people of all ages. 

Market Dynamics 

The growing cases of gastrointestinal disorders among the global population will be the main driving force behind this market's growth. The increasing geriatric population, changing dietary habits, and sedentary lifestyles are the leading causes of CIC that will further propel market growth. The heavy investments made towards developing novel therapeutic drugs and emerging treatment methods for CIC will be a market booster. The advancements in drug delivery, high disposable income, and favorable reimbursement policies will augment the market growth. Increasing expenditure on the healthcare sector worldwide will favor market growth. The major hindrance to this market's development is the lack of awareness about the various diagnosis and treatment options available to control CIC. 

The research report covers Porter’s Five Forces Model, Market Attractiveness Analysis, and Value Chain analysis. These tools help to get a clear picture of the industry’s structure and evaluate the competition attractiveness at a global level. Additionally, these tools also give an inclusive assessment of each segment in the global market of chronic idiopathic constipation treatment. The growth and trends of chronic idiopathic constipation treatment industry provide a holistic approach to this study. 

Market Segmentation

This section of the chronic idiopathic constipation treatment market report provides detailed data on the segments at country and regional level, thereby assisting the strategist in identifying the target demographics for the respective product or services with the upcoming opportunities. 

By Type 
  • Normal-transit Constipation
  • Slow-transit Constipation
  • Others
By Therapy Type
  • Pharmacological Therapy
  • Non-pharmacological Therapy
By Treatment Type
  • Medication (Prescription Drugs, Over the Counter Drugs)
  • Surgery (Laparoscopic Rectopexy, Lateral internal sphincterotomy)
  • Dietary Fiber
By Drugs
  • Serotonin-4 (5-Ht4) Receptor Agonist
  • Guanylate Cyclase-C Agonist
  • Laxatives
  • Stimulants
  • Others
By Route of Administration
  • Oral
  • Injectable
By End Users
  • Hospitals
  • Homecare
  • Specialty Clinics
  • Others
By Distribution Channel
  • Hospital Pharmacies
  • Retail Pharmacies
  • Others
Regional Analysis

This section covers the regional outlook, which accentuates current and future demand for the Chronic Idiopathic Constipation Treatment market across North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. Further, the report focuses on demand, estimation, and forecast for individual application segments across all the prominent regions.

Global Chronic Idiopathic Constipation Treatment Market Share by Region (Representative Graph)

Global Chronic Idiopathic Constipation Treatment Market Share


The research report also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide. The major players in the chronic idiopathic constipation treatment market include GlaxoSmithKline Plc., Bayer AG, Allergan Plc., Ironwood Pharmaceuticals, Inc., Astellas Pharma, Inc., Synergy Pharmaceuticals, Inc., Sanofi S.A., and Pfizer, Inc. By Type This section consists of a holistic view of the competitive landscape that includes various strategic developments such as key mergers & acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developments.
 
METHODOLOGY:

This market research report has been produced by gathering information based on primary and secondary research. Secondary research has been done using various sources, including (but not limited to) Company Websites, Paid Data Sources, Technical Journals, Financial Reports, SEC Filings, and other different industry publications. Additionally, our team conducts extensive primary research with key industry participants to gather first-hand data. The data is then analyzed and validated by industry experts.

In case you have any custom requirements, do write to us. Our research team can offer a customized report as per your need.

1 . PREFACE
       1.1. Report Description
           1.1.1. Objective
           1.1.2. Target Audience
           1.1.3. Unique Selling Proposition (USP) & offerings
       1.2. Research Scope
       1.3. Research Methodology
           1.3.1. Market Research Process
           1.3.2. Market Research Methodology
 
2 . EXECUTIVE SUMMARY
       2.1. Highlights of Market
       2.2. Global Market Snapshot
 
3 . CHRONIC IDIOPATHIC CONSTIPATION TREATMENT – INDUSTRY ANALYSIS
       3.1. Introduction - Market Dynamics
       3.2. Market Drivers
       3.3. Market Restraints
       3.4. Opportunities
       3.5. Industry Trends
       3.6. Porter’s Five Force Analysis
       3.7. Market Attractiveness Analysis
           3.7.1 By Type
           3.7.2 By Therapy Type
           3.7.3 By Treatment Type
           3.7.4 By Drugs
           3.7.5 By Route of Administration
           3.7.6 By End Users
           3.7.7 By Distribution Channel
           3.7.8 By Region
 
4 . VALUE CHAIN ANALYSIS
       4.1. Value Chain Analysis
       4.2. Raw Material Analysis
           4.2.1. List of Raw Materials
           4.2.2. Raw Material Manufactures List
           4.2.3. Price Trend of Key Raw Materials
       4.3. List of Potential Buyers
       4.4. Marketing Channel
           4.4.1. Direct Marketing
           4.4.2. Indirect Marketing
           4.4.3. Marketing Channel Development Trend
 
5 . IMPACT ANALYSIS OF COVID-19 OUTBREAK
       5.1. Impact Analysis of Covid-19 Outbreak
           5.1.1. Direct Impact on Production
           5.1.2. Supply Chain and Market Disruption
           5.1.3. Financial Impact on Firms and Financial Markets
       5.2. COVID-19 Impact Analysis by Production, Import, Export and Demand
       5.3. Market: Pre V/S Post COVID-19
       5.4. Estimated Impact of the Coronavirus (COVID-19) Epidemic
       5.5. COVID-19: Micro and Macro Factor Analysis
 
6 . GLOBAL CHRONIC IDIOPATHIC CONSTIPATION TREATMENT MARKET ANALYSIS BY TYPE
       6.1 Overview by Type
       6.2 Historical and Forecast Data
       6.3 Analysis by Type
       6.4 Normal-transit Constipation Market by Regions
       6.5 Slow-transit Constipation Market by Regions
       6.6 Others Market by Regions
 
7 . GLOBAL CHRONIC IDIOPATHIC CONSTIPATION TREATMENT MARKET ANALYSIS BY THERAPY TYPE
       7.1 Overview by Therapy Type
       7.2 Historical and Forecast Data
       7.3 Analysis by Therapy Type
       7.4 Pharmacological Therapy Market by Regions
       7.5 Non-pharmacological Therapy Market by Regions
 
8 . GLOBAL CHRONIC IDIOPATHIC CONSTIPATION TREATMENT MARKET ANALYSIS BY TREATMENT TYPE
       8.1 Overview by Treatment Type
       8.2 Historical and Forecast Data
       8.3 Analysis by Treatment Type
       8.4 Medication (Prescription Drugs, Over the Counter Drugs) Market by Regions
       8.5 Surgery (Laparoscopic Rectopexy, Lateral internal sphincterotomy) Market by Regions
       8.6 Dietary Fiber Market by Regions
 
9 . GLOBAL CHRONIC IDIOPATHIC CONSTIPATION TREATMENT MARKET ANALYSIS BY DRUGS
       9.1 Overview by Drugs
       9.2 Historical and Forecast Data
       9.3 Analysis by Drugs
       9.4 Serotonin-4 (5-Ht4) Receptor Agonist Market by Regions
       9.5 Guanylate Cyclase-C Agonist Market by Regions
       9.6 Laxatives Market by Regions
       9.7 Stimulants Market by Regions
       9.8 Others Market by Regions
 
10 . GLOBAL CHRONIC IDIOPATHIC CONSTIPATION TREATMENT MARKET ANALYSIS BY ROUTE OF ADMINISTRATION
       10.1 Overview by Route of Administration
       10.2 Historical and Forecast Data
       10.3 Analysis by Route of Administration
       10.4 Oral Market by Regions
       10.5 Injectable Market by Regions
 
11 . GLOBAL CHRONIC IDIOPATHIC CONSTIPATION TREATMENT MARKET ANALYSIS BY END USERS
       11.1 Overview by End Users
       11.2 Historical and Forecast Data
       11.3 Analysis by End Users
       11.4 Hospitals Market by Regions
       11.5 Homecare Market by Regions
       11.6 Specialty Clinics Market by Regions
       11.7 Others Market by Regions
 
12 . GLOBAL CHRONIC IDIOPATHIC CONSTIPATION TREATMENT MARKET ANALYSIS BY DISTRIBUTION CHANNEL
       12.1 Overview by Distribution Channel
       12.2 Historical and Forecast Data
       12.3 Analysis by Distribution Channel
       12.4 Hospital Pharmacies Market by Regions
       12.5 Retail Pharmacies Market by Regions
       12.6 Others Market by Regions
 
13 . GLOBAL CHRONIC IDIOPATHIC CONSTIPATION TREATMENT MARKET ANALYSIS BY GEOGRAPHY
       13.1. Regional Outlook
       13.2. Introduction
       13.3. North America
           13.3.1. Overview, Historic and Forecast Data
           13.3.2. North America By Segment
           13.3.3. North America By Country
           13.3.4. United State
           13.3.5. Canada
           13.3.6. Mexico
       13.4. Europe
           13.4.1. Overview, Historic and Forecast Data
           13.4.2. Europe by Segment
           13.4.3. Europe by Country
           13.4.4. United Kingdom
           13.4.5. France
           13.4.6. Germany
           13.4.7. Italy
           13.4.8. Russia
           13.4.9. Rest Of Europe
       13.5. Asia Pacific
           13.5.1. Overview, Historic and Forecast Data
           13.5.2. Asia Pacific by Segment
           13.5.3. Asia Pacific by Country
           13.5.4. China
           13.5.5. India
           13.5.6. Japan
           13.5.7. South Korea
           13.5.8. Australia
           13.5.9. Rest Of Asia Pacific
       13.6. Latin America
           13.6.1. Overview, Historic and Forecast Data
           13.6.2. Latin America by Segment
           13.6.3. Latin America by Country
           13.6.4. Brazil
           13.6.5. Argentina
           13.6.6. Peru
           13.6.7. Chile
           13.6.8. Rest of Latin America
       13.7. Middle East & Africa
           13.7.1. Overview, Historic and Forecast Data
           13.7.2. Middle East & Africa by Segment
           13.7.3. Middle East & Africa by Country
           13.7.4. Saudi Arabia
           13.7.5. UAE
           13.7.6. Israel
           13.7.7. South Africa
           13.7.8. Rest Of Middle East And Africa
 
14 . COMPETITIVE LANDSCAPE OF THE CHRONIC IDIOPATHIC CONSTIPATION TREATMENT COMPANIES
       14.1. Chronic Idiopathic Constipation Treatment Market Competition
       14.2. Partnership/Collaboration/Agreement
       14.3. Merger And Acquisitions
       14.4. New Product Launch
       14.5. Other Developments
 
15 . COMPANY PROFILES OF CHRONIC IDIOPATHIC CONSTIPATION TREATMENT INDUSTRY
       15.1. Company Share Analysis
       15.2. Market Concentration Rate
       15.3. GlaxoSmithKline Plc.
           15.3.1. Company Overview
           15.3.2. Financials
           15.3.3. Products
           15.3.4. Recent Developments
       15.4. Bayer AG
           15.4.1. Company Overview
           15.4.2. Financials
           15.4.3. Products
           15.4.4. Recent Developments
       15.5. Allergan Plc.
           15.5.1. Company Overview
           15.5.2. Financials
           15.5.3. Products
           15.5.4. Recent Developments
       15.6. Ironwood Pharmaceuticals, Inc.
           15.6.1. Company Overview
           15.6.2. Financials
           15.6.3. Products
           15.6.4. Recent Developments
       15.7. Astellas Pharma, Inc.
           15.7.1. Company Overview
           15.7.2. Financials
           15.7.3. Products
           15.7.4. Recent Developments
       15.8. Synergy Pharmaceuticals, Inc.
           15.8.1. Company Overview
           15.8.2. Financials
           15.8.3. Products
           15.8.4. Recent Developments
       15.9. Sanofi S.A.
           15.9.1. Company Overview
           15.9.2. Financials
           15.9.3. Products
           15.9.4. Recent Developments
       15.10. Pfizer, Inc.
           15.10.1. Company Overview
           15.10.2. Financials
           15.10.3. Products
           15.10.4. Recent Developments
 
 *Note - in company profiling, financial details and recent development are subject to availability or might not be covered in case of private companies
 
LIST OF TABLES

  • Market Snapshot
  • Drivers : Impact Analysis
  • Restraints : Impact Analysis
  • List of Raw Material
  • List of Raw Material Manufactures
  • List of Potential Buyers
  • COVID-19 Impact Analysis by Production, Import, Export and Demand
  • Pre V/S Post COVID-19
  • Estimated Impact Of The Coronavirus (Covid-19) Epidemic
  • COVID-19: Micro and Macro Factor Analysis
  • Analysis by Type  (USD MN)
  • Normal-transit Constipation Market by Geography (USD MN)
  • Slow-transit Constipation Market by Geography (USD MN)
  • Others Market by Geography (USD MN)
  • Analysis Market by Therapy Type (USD MN)
  • Pharmacological Therapy Market by Geography (USD MN)
  • Non-pharmacological Therapy Market by Geography (USD MN)
  • Analysis by Treatment Type (USD MN)
  • Medication (Prescription Drugs, Over the Counter Drugs) Market by Geography (USD MN)
  • Surgery (Laparoscopic Rectopexy, Lateral internal sphincterotomy) Market by Geography (USD MN)
  • Dietary Fiber Market by Geography (USD MN)
  • Analysis by Drugs (USD MN)
  • Serotonin-4 (5-Ht4) Receptor Agonist Market by Geography (USD MN)
  • Guanylate Cyclase-C Agonist Market by Geography (USD MN)
  • Laxatives Market by Geography (USD MN)
  • Stimulants Market by Geography (USD MN)
  • Others Market by Geography (USD MN)
  • Analysis by Route of Administration (USD MN)
  • Oral Market by Geography (USD MN)
  • Injectable Market by Geography (USD MN)
  • Analysis by End Users (USD MN)
  • Hospitals Market by Geography (USD MN)
  • Homecare Market by Geography (USD MN)
  • Specialty Clinics Market by Geography (USD MN)
  • Others Market by Geography (USD MN)
  • Analysis by Distribution Channel (USD MN)
  • Hospital Pharmacies Market by Geography (USD MN)
  • Retail Pharmacies Market by Geography (USD MN)
  • Others Market by Geography (USD MN)
  • Global Chronic Idiopathic Constipation Treatment Market by Geography (USD MN)
  • North America Market Analysis (USD MN)
  • United State Market Analysis (USD MN)
  • Canada Market Analysis (USD MN)
  • Mexico Market Analysis (USD MN)
  • Europe Market Analysis (USD MN)
  • Europe Market Estimate by Country (USD MN)
  • United Kingdom Market Analysis (USD MN)
  • France Market Analysis (USD MN)
  • Germany Market Analysis (USD MN)
  • Italy Market Analysis (USD MN)
  • Russia Market Analysis (USD MN)
  • Spain Market Analysis (USD MN)
  • Rest of Europe Market Analysis (USD MN)
  • Asia Pacific Market Analysis (USD MN)
  • China Market Analysis (USD MN)
  • Japan Market Analysis (USD MN)
  • India Market Analysis (USD MN)
  • South Korea Market Analysis (USD MN)
  • Australia Market Analysis (USD MN)
  • Rest of Asia Pacific Market Analysis (USD MN)
  • Latin America Market Analysis (USD MN)
  • Brazil Market Analysis (USD MN)
  • Argentina Market Analysis (USD MN)
  • Peru Market Analysis (USD MN)
  • Chile Market Analysis (USD MN)
  • Rest of Latin America Market Analysis (USD MN)
  • Middle East & Africa Market Analysis (USD MN)
  • Saudi Arabia Market Analysis (USD MN)
  • UAE Market Analysis (USD MN)
  • Israel Market Analysis (USD MN)
  • South Africa Market Analysis (USD MN)
  • Rest of Middle East and Africa Market Analysis (USD MN)
  • Partnership/Collaboration/Agreement
  • Mergers And Acquisiton
 
LIST OF FIGURES
 
  • Research Scope of Chronic Idiopathic Constipation Treatment Report
  • Market Research Process
  • Market Research Methodology
  • Global Chronic Idiopathic Constipation Treatment Market Size, by Region (USD MN)
  • Porters Five Forces Analysis
  • Market Attractiveness Analysis by Type
  • Market Attractiveness Analysis by Therapy Type
  • Market Attractiveness Analysis by Treatment Type
  • Market Attractiveness Analysis by Drugs
  • Market Attractiveness Analysis by Route of Administration
  • Market Attractiveness Analysis by End Users
  • Market Attractiveness Analysis by Distribution Channel
  • Market Attractiveness Analysis by Region
  • Value Chain Analysis
  • Global Market Analysis by Type  (USD MN)
  • Normal-transit Constipation Market by Geography (USD MN)
  • Slow-transit Constipation Market by Geography (USD MN)
  • Others Market by Geography (USD MN)
  • Global Market Analysis by Therapy Type (USD MN)
  • Pharmacological Therapy Market by Geography (USD MN)
  • Non-pharmacological Therapy Market by Geography (USD MN)
  • Global Market Analysis by Treatment Type (USD MN)
  • Medication (Prescription Drugs, Over the Counter Drugs) Market by Geography (USD MN)
  • Surgery (Laparoscopic Rectopexy, Lateral internal sphincterotomy) Market by Geography (USD MN)
  • Dietary Fiber Market by Geography (USD MN)
  • Global Market Analysis by Drugs (USD MN)
  • Serotonin-4 (5-Ht4) Receptor Agonist Market by Geography (USD MN)
  • Guanylate Cyclase-C Agonist Market by Geography (USD MN)
  • Laxatives Market by Geography (USD MN)
  • Stimulants Market by Geography (USD MN)
  • Others Market by Geography (USD MN)
  • Global Market Analysis by Route of Administration (USD MN)
  • Oral Market by Geography (USD MN)
  • Injectable Market by Geography (USD MN)
  • Global Market Analysis by End Users (USD MN)
  • Hospitals Market by Geography (USD MN)
  • Homecare Market by Geography (USD MN)
  • Specialty Clinics Market by Geography (USD MN)
  • Others Market by Geography (USD MN)
  • Global Market Analysis by Distribution Channel (USD MN)
  • Hospital Pharmacies Market by Geography (USD MN)
  • Retail Pharmacies Market by Geography (USD MN)
  • Others Market by Geography (USD MN)
  • Global Market by Revenue
  • North America Market by Revenue
  • Europe Market by Revenue
  • Asia Pacific Market by Revenue
  • Latin America Market by Revenue
  • Middle East & Africa Market by Revenue
  • Recent Development in Industry
  • Company Market Share Analysis, 2020
 
* Kindly note that the above listed are the basic tables and figures of the report and are not limited to the TOC.

Buy Chapters or Sections

Avail customized purchase options to meet your exact research needs:

  • Buy sections of this report
  • Buy country level reports
  • Request for historical data
  • Request discounts available for Start-Ups & Universities

Objectives of Study

  • Define and measure the global market
  • Volume or revenue forecast of the global market and its various sub-segments with respect to main geographies
  • Analyze and identify major market trends along with the factors driving or inhibiting the market growth
  • Study the company profiles of the major market players with their market share
  • Analyze competitive developments

Why Choose Us

Client First Policy
Excellent Quality
Robust After Sales Support
24/7 Email Support

Clients

Testimonials